Personalized cancer therapy is now a reality. A handful of tumor-classifying tests and targeted drugs are in widespread clinical use; and early attempts are underway to match high-risk cancer patients to experimental drugs based on genetic testing of their tumors.

The last ten years have seen huge leaps in biomedical computing.